These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

958 related articles for article (PubMed ID: 12441176)

  • 1. Mechanisms involved in the side effects of glucocorticoids.
    Schäcke H; Döcke WD; Asadullah K
    Pharmacol Ther; 2002 Oct; 96(1):23-43. PubMed ID: 12441176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEGRAs: a novel class of anti-inflammatory compounds.
    Schäcke H; Hennekes H; Schottelius A; Jaroch S; Lehmann M; Schmees N; Rehwinkel H; Asadullah K
    Ernst Schering Res Found Workshop; 2002; (40):357-71. PubMed ID: 12355726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
    De Bosscher K; Beck IM; Haegeman G
    Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucocorticoids and their receptor: mechanisms of action and clinical implications].
    Roumestan C; Gougat C; Jaffuel D; Mathieu M
    Rev Med Interne; 2004 Sep; 25(9):636-47. PubMed ID: 15363619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
    Ayroldi E; Macchiarulo A; Riccardi C
    FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
    Newton R; Holden NS
    Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
    Patel GC; Millar JC; Clark AF
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glucocorticoid receptor agonistic modulators CpdX and CpdX-D3 do not generate the debilitating effects of synthetic glucocorticoids.
    Hua G; Zein N; Paulen L; Chambon P
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14200-14209. PubMed ID: 31221758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociated glucocorticoid receptor ligands.
    Schäcke H; Rehwinkel H
    Curr Opin Investig Drugs; 2004 May; 5(5):524-8. PubMed ID: 15202726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
    Vandevyver S; Dejager L; Tuckermann J; Libert C
    Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the novel anti-inflammatory mode of action of glucocorticoids.
    Ingawale DK; Mandlik SK
    Immunopharmacol Immunotoxicol; 2020 Apr; 42(2):59-73. PubMed ID: 32070175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity.
    Belvisi MG; Wicks SL; Battram CH; Bottoms SE; Redford JE; Woodman P; Brown TJ; Webber SE; Foster ML
    J Immunol; 2001 Feb; 166(3):1975-82. PubMed ID: 11160246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects.
    Du J; Cheng B; Zhu X; Ling C
    J Immunol; 2011 Jul; 187(2):942-50. PubMed ID: 21666059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds.
    Sundahl N; Bridelance J; Libert C; De Bosscher K; Beck IM
    Pharmacol Ther; 2015 Aug; 152():28-41. PubMed ID: 25958032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy.
    Schoepe S; Schäcke H; Bernd A; Zöller N; Asadullah K
    Skin Pharmacol Physiol; 2010; 23(3):139-51. PubMed ID: 20051715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociated steroids.
    Catley M
    ScientificWorldJournal; 2007 Mar; 7():421-30. PubMed ID: 17450306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of action of glucocorticoids].
    Dejean C; Richard D
    Rev Med Interne; 2013 May; 34(5):264-8. PubMed ID: 23498716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.